دورية أكاديمية
Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey.
العنوان: | Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey. |
---|---|
المؤلفون: | Ueki D; Department of Pharmacy, National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan., Suzuki S; Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan., Ohta T; Department of Pharmacy, National Hospital Organization Tokyo Medical Center, Tokyo 152-8902, Japan., Shinohara A; Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan., Ohashi Y; Department of Pharmacy, National Center for Global Health and Medicine, Tokyo 162-8655, Japan., Konuma D; Department of Pharmacy, National Hospital Organization Chiba Medical Center, Chiba 260-8606, Japan., Ryushima Y; Department of Pharmacy, National Hospital Organization Saitama Hospital, Saitama 351-0102, Japan., Udagawa R; Department of Pharmacy, National Cancer Center Hospital, Tokyo 104-0045, Japan., Motoshige H; Department of Pharmacy, National Hospital Organization Hokkaido Medical Center, 5-7 Yamanote, Nishi-ku, Sapporo 063-0005, Japan., Ieoka M; Department of Pharmacy, National Hospital Organization Hamada Medical Center, Matsue 697-8511, Japan., Taji A; Department of Pharmacy, National Hospital Organization Osaka Minami Medical Center, Osaka 586-8521, Japan., Kogure Y; Department of Pharmacy, National Hospital Organization Higashihiroshima Medical Center, Hiroshima 739-0041, Japan., Hiraike M; Department of Pharmacy, National Hospital Organization Kumamoto Medical Center, Kumamoto 860-0008, Japan., Uoi M; Department of Pharmacy, National Hospital Organization Kyusyu Cancer Center, Fukuoka 811-1395, Japan., Ino K; Department of Pharmacy, National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan., Kawasaki T; Department of Pharmacy, National Cancer Center Hospital East, Chiba 277-8577, Japan., Yamaguchi M; Department of Pharmacy, Cancer Institute Hospital, Tokyo 135-8550, Japan. |
المصدر: | Pharmacy (Basel, Switzerland) [Pharmacy (Basel)] 2023 Dec 20; Vol. 12 (1). Date of Electronic Publication: 2023 Dec 20. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101678532 Publication Model: Electronic Cited Medium: Internet ISSN: 2226-4787 (Electronic) Linking ISSN: 22264787 NLM ISO Abbreviation: Pharmacy (Basel) Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
مستخلص: | Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to investigate the implementation of chemotherapy regimen checks by pharmacists in general hospitals by focusing on 19 recommended confirmation items designed to enhance chemotherapy safety. This study involved 14 hospitals within the National Hospital Organization in different regions of Japan. The top five cancers in Japan (gastric, colorectal, lung, breast, and gynecological) were targeted and specific chemotherapy regimens were analyzed. This study assessed the amount of time required for regimen checks, the number of confirmation items completed, the number and the content of inquiries raised regarding prescriptions, and the pharmacists' opinions using a questionnaire that had a maximum score of 10 points. Pharmacists checked 345 and 375 chemotherapies of patients in the control group (CG) and recommended items group (RIG), respectively. The mean time periods required for completing a chemotherapy regimen check were 4 min and 14 s (SD ±1 min and 50 s) and 6 min and 18 s (SD, ±1 min and 7 s) in the CG and RIG, respectively. The mean of the recommended items for the CG = 12.4 and for the RIG = 18.6. The items that the pharmacists did not confirm included urine protein (sixty-nine cases, 18.4%), allergy history (four cases, 1%), previous history (two cases, 0.5%), and a previous history of hepatitis B virus (sixty-nine cases, 18.4%). The number of inquiries for a doctor's prescription order was higher in the RIG than in the CG (41 vs. 27 cases). This multicenter survey demonstrated the potential effectiveness of implementing 19 recommended confirmation items in the regimen checks by pharmacists in general hospitals other than cancer treatment collaborative base hospitals. |
References: | Chemotherapy. 2013;59(5):330-7. (PMID: 24801809) J Oncol Pract. 2012 Jan;8(1):2-6. (PMID: 22548003) SAGE Open Med. 2020 Jun 12;8:2050312120930906. (PMID: 32587691) Am J Health Syst Pharm. 1998 Jan 15;55(2):137-44. (PMID: 9465977) J Pharm Health Care Sci. 2015 Mar 05;1:10. (PMID: 26819721) J Oncol Pract. 2017 Apr;13(4):e329-e336. (PMID: 28260404) J Oncol Pharm Pract. 2014 Dec;20(6):445-60. (PMID: 24356802) Farm Hosp. 2007 May-Jun;31(3):161-4. (PMID: 17941754) J Oncol Pract. 2016 Feb;12(2):168-9; e180-7. (PMID: 26420888) J Oncol Pharm Pract. 2019 Oct;25(7):1558-1563. (PMID: 30180775) World J Hepatol. 2015 Sep 28;7(21):2344-51. (PMID: 26413224) Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e56-e61. (PMID: 32576572) Jpn J Clin Oncol. 2017 May 01;47(5):413-421. (PMID: 28184436) Int J Clin Pharm. 2016 Oct;38(5):1326-35. (PMID: 27573721) J Oncol Pharm Pract. 2022 Mar;28(2):410-420. (PMID: 33622088) Arch Intern Med. 2006 Mar 13;166(5):565-71. (PMID: 16534045) Bone Marrow Transplant. 2013 Mar;48(3):452-8. (PMID: 23208313) Res Social Adm Pharm. 2019 Jun;15(6):754-760. (PMID: 30243575) J Oncol Pharm Pract. 2017 Jan;23(1):18-25. (PMID: 26561587) Pediatr Blood Cancer. 2013 Aug;60(8):1320-4. (PMID: 23519908) J Pharm Health Care Sci. 2019 Jul 03;5:14. (PMID: 31308953) Front Pharmacol. 2023 Jun 29;14:1195732. (PMID: 37456737) J Adv Nurs. 2021 Feb;77(2):899-909. (PMID: 33210337) |
فهرسة مساهمة: | Keywords: cancer chemotherapy; chemotherapy regimen checks; hospital pharmacist; pharmacist intervention |
تواريخ الأحداث: | Date Created: 20240223 Latest Revision: 20240227 |
رمز التحديث: | 20240227 |
مُعرف محوري في PubMed: | PMC10891652 |
DOI: | 10.3390/pharmacy12010001 |
PMID: | 38392922 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2226-4787 |
---|---|
DOI: | 10.3390/pharmacy12010001 |